Connection

JASON ERIKSEN to Animals

This is a "connection" page, showing publications JASON ERIKSEN has written about Animals.
Connection Strength

0.332
  1. Formaldehyde scavengers function as novel antigen retrieval agents. Sci Rep. 2015 Nov 27; 5:17322.
    View in: PubMed
    Score: 0.024
  2. Long-term treadmill exercise attenuates tau pathology in P301S tau transgenic mice. Mol Neurodegener. 2014 Nov 28; 9:54.
    View in: PubMed
    Score: 0.022
  3. Elevated prostacyclin biosynthesis in mice impacts memory and anxiety-like behavior. Behav Brain Res. 2014 Jan 01; 258:138-44.
    View in: PubMed
    Score: 0.020
  4. Chronic treatment with DCPCX, an adenosine A(1) antagonist, worsens long-term memory. Neurosci Lett. 2013 Aug 26; 548:296-300.
    View in: PubMed
    Score: 0.020
  5. The enigmatic roles of microglial versus neuronal progranulin in neurological disease. Acta Neuropathol. 2010 Jan; 119(1):107-9.
    View in: PubMed
    Score: 0.016
  6. Biologic models of neurodegenerative disorders. Handb Clin Neurol. 2008; 89:173-88.
    View in: PubMed
    Score: 0.014
  7. Progranulin: normal function and role in neurodegeneration. J Neurochem. 2008 Jan; 104(2):287-97.
    View in: PubMed
    Score: 0.014
  8. Plaques, tangles, and memory loss in mouse models of neurodegeneration. Behav Genet. 2007 Jan; 37(1):79-100.
    View in: PubMed
    Score: 0.013
  9. Gene dosage and pathogenesis of Parkinson's disease. Trends Mol Med. 2005 Mar; 11(3):91-6.
    View in: PubMed
    Score: 0.011
  10. Molecular pathogenesis of Parkinson disease. Arch Neurol. 2005 Mar; 62(3):353-7.
    View in: PubMed
    Score: 0.011
  11. Caught in the act: alpha-synuclein is the culprit in Parkinson's disease. Neuron. 2003 Oct 30; 40(3):453-6.
    View in: PubMed
    Score: 0.010
  12. NSAIDs and enantiomers of flurbiprofen target gamma-secretase and lower Abeta 42 in vivo. J Clin Invest. 2003 Aug; 112(3):440-9.
    View in: PubMed
    Score: 0.010
  13. Effects of ethanol and 5-HT1A agonists on astroglial S100B. Brain Res Dev Brain Res. 2002 Dec 15; 139(2):97-105.
    View in: PubMed
    Score: 0.010
  14. A surrogate marker for very early-stage tau pathology is detectable by molecular magnetic resonance imaging. Theranostics. 2022; 12(12):5504-5521.
    View in: PubMed
    Score: 0.009
  15. One-Step Transformation from Rofecoxib to a COX-2 NIR Probe for Human Cancer Tissue/Organoid Targeted Bioimaging. ACS Appl Bio Mater. 2021 03 15; 4(3):2723-2731.
    View in: PubMed
    Score: 0.009
  16. Cycad Genotoxin Methylazoxymethanol Disrupts the Brain Ubiquitin-Proteasome Pathway, Tau and a-Synuclein, as Reported in ALS-PDC. J Neuropathol Exp Neurol. 2021 02 22; 80(3):286-288.
    View in: PubMed
    Score: 0.009
  17. Exercise training ameliorates cerebrovascular dysfunction in a murine model of Alzheimer's disease: role of the P2Y2 receptor and endoplasmic reticulum stress. Am J Physiol Heart Circ Physiol. 2020 06 01; 318(6):H1559-H1569.
    View in: PubMed
    Score: 0.008
  18. Three-Dimensional Microscopy by Milling with Ultraviolet Excitation. Sci Rep. 2019 10 10; 9(1):14578.
    View in: PubMed
    Score: 0.008
  19. 7B2 chaperone knockout in APP model mice results in reduced plaque burden. Sci Rep. 2018 06 28; 8(1):9813.
    View in: PubMed
    Score: 0.007
  20. Robust Tracing and Visualization of Heterogeneous Microvascular Networks. IEEE Trans Vis Comput Graph. 2019 04; 25(4):1760-1773.
    View in: PubMed
    Score: 0.007
  21. Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition). Autophagy. 2016; 12(1):1-222.
    View in: PubMed
    Score: 0.006
  22. A Novel Liposomal Nanoparticle for the Imaging of Amyloid Plaque by Magnetic Resonance Imaging. J Alzheimers Dis. 2016; 52(2):731-45.
    View in: PubMed
    Score: 0.006
  23. Characterization of Polymyxin B Biodistribution and Disposition in an Animal Model. Antimicrob Agents Chemother. 2016 Feb; 60(2):1029-34.
    View in: PubMed
    Score: 0.006
  24. Regular exercise prevents non-cognitive disturbances in a rat model of Alzheimer's disease. Int J Neuropsychopharmacol. 2014 Apr; 17(4):593-602.
    View in: PubMed
    Score: 0.005
  25. A novel function for proSAAS as an amyloid anti-aggregant in Alzheimer's disease. J Neurochem. 2014 Feb; 128(3):419-30.
    View in: PubMed
    Score: 0.005
  26. Treadmill exercise prevents learning and memory impairment in Alzheimer's disease-like pathology. Curr Alzheimer Res. 2013 06; 10(5):507-15.
    View in: PubMed
    Score: 0.005
  27. Inhibitory neuron and hippocampal circuit dysfunction in an aged mouse model of Alzheimer's disease. PLoS One. 2013; 8(5):e64318.
    View in: PubMed
    Score: 0.005
  28. ?2-Adrenoceptor agonists are required for development of the asthma phenotype in a murine model. Am J Respir Cell Mol Biol. 2013 Feb; 48(2):220-9.
    View in: PubMed
    Score: 0.005
  29. The neuroendocrine protein 7B2 suppresses the aggregation of neurodegenerative disease-related proteins. J Biol Chem. 2013 Jan 11; 288(2):1114-24.
    View in: PubMed
    Score: 0.005
  30. Intravenous delivery of targeted liposomes to amyloid-? pathology in APP/PSEN1 transgenic mice. PLoS One. 2012; 7(10):e48515.
    View in: PubMed
    Score: 0.005
  31. Aging is not associated with proteasome impairment in UPS reporter mice. PLoS One. 2009 Jun 11; 4(6):e5888.
    View in: PubMed
    Score: 0.004
  32. Substrate-targeting gamma-secretase modulators. Nature. 2008 Jun 12; 453(7197):925-9.
    View in: PubMed
    Score: 0.004
  33. Chronic administration of R-flurbiprofen attenuates learning impairments in transgenic amyloid precursor protein mice. BMC Neurosci. 2007 Jul 24; 8:54.
    View in: PubMed
    Score: 0.003
  34. An inhibitor of tau hyperphosphorylation prevents severe motor impairments in tau transgenic mice. Proc Natl Acad Sci U S A. 2006 Jun 20; 103(25):9673-8.
    View in: PubMed
    Score: 0.003
  35. A decade of modeling Alzheimer's disease in transgenic mice. Trends Genet. 2006 May; 22(5):281-9.
    View in: PubMed
    Score: 0.003
  36. Abeta42 is essential for parenchymal and vascular amyloid deposition in mice. Neuron. 2005 Jul 21; 47(2):191-199.
    View in: PubMed
    Score: 0.003
  37. The non-cyclooxygenase targets of non-steroidal anti-inflammatory drugs, lipoxygenases, peroxisome proliferator-activated receptor, inhibitor of kappa B kinase, and NF kappa B, do not reduce amyloid beta 42 production. J Biol Chem. 2003 Aug 22; 278(34):31825-30.
    View in: PubMed
    Score: 0.002
  38. Evidence that nonsteroidal anti-inflammatory drugs decrease amyloid beta 42 production by direct modulation of gamma-secretase activity. J Biol Chem. 2003 Aug 22; 278(34):31831-7.
    View in: PubMed
    Score: 0.002
  39. Abeta42-lowering nonsteroidal anti-inflammatory drugs preserve intramembrane cleavage of the amyloid precursor protein (APP) and ErbB-4 receptor and signaling through the APP intracellular domain. J Biol Chem. 2003 Aug 15; 278(33):30748-54.
    View in: PubMed
    Score: 0.002
  40. Effects of ethanol and ipsapirone on the development of midline raphe glial cells and astrocytes. Alcohol. 2003 Apr; 29(3):157-64.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.